• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr William Borden Discusses MACRA Requirements From a Cardiologist's Perspective

Video

As CMS developed the Medicare Access and CHIP Reauthorization Act (MACRA) over the past few years, it was responsive to the needs and concerns of clinicians, according to William Borden, MD, FACC, FAHA, associate professor of medicine and director of healthcare delivery transformation at the George Washington University. Still, Borden says there are ways the requirements could be simplified, which would benefit both physicians and patients.

As CMS developed the Medicare Access and CHIP Reauthorization Act (MACRA) over the past few years, it was responsive to the needs and concerns of clinicians, according to William Borden, MD, FACC, FAHA, associate professor of medicine and director of healthcare delivery transformation at the George Washington University. Still, Borden says there are ways the requirements could be simplified, which would benefit both physicians and patients.

Transcript (slightly modified)

Do you think that CMS took the physician perspective into account when developing MACRA?

I do think so. I think specifically with the final rule that came out this past fall, there was a lot of physician input. There was a lot of concern about small and rural practices and the speed at which MACRA’s being rolled out. CMS was responsive to that and instituted the pick your pace policy at least for 2017, and so I think that it’s definitely being responsive and looking at providing tools for providers to allow them to be successful.

I think there are still some remaining issues. I think that small and rural practices as they look to 2018 still have some concerns. The availability of APMs for a variety of providers including cardiologists is an issue. And then I think the flexibility and availability of the EHRs to really provide the data feedback that’s necessary to be successful in these programs, these are all areas where there is provider input and I think that there still remain some opportunities.

If you could change anything about the MACRA requirements, what would it be?

If I could change 1 thing about MACRA, I think it would be around simplifying the quality measures. There’s still a substantial amount of time when face to face with the patient, with the physicians after that time, with administrative staff in trying to meet these quality measures, so I think simplifying or reducing the administrative burden. And then also continuing, which Medicare has done, in moving towards more outcome measures and measures that are truly meaningful for the outcomes our patients care about.

Related Videos
Khush Kharidia, MD
Kimberly Westrich, MA, chief strategy officer, National Pharmaceutical Council
Harry Travis, BS Pharm, MBA, president at The Travis Group, LLC
 Brigid Groves, PharmD, MS, vice president, professional affairs, American Pharmacists Association
Chelsea Renfro, PharmD, research and engagement pharmacist, Vanderbilt Specialty Pharmacy
Chicago skyline with words "CHEST 2025 Recap Chicago, Illinois" | Image credit: SeanPavonePhoto - stock.adobe.com
Screenshot of an interview with Kristina Crothers, MD
James Simon, MD – Image credit: AJMC
Brooke Aggarwal, EdD – screenshot by AJMC
JoAnn Pinkerton, MD
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.